- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CRSP
Recent news which mentions CRSP
2 Soaring Stocks to Buy and Hold Through 2023 and Beyond
March 03, 2023
From Motley Fool
10 Best Stocks to Buy in March 2023
March 01, 2023
From Motley Fool
Here's How Much You Can Make From Investing Your Tax Return Every Year
February 27, 2023
From Motley Fool
Looking Into CRISPR Therapeutics's Return On Invested Capital
February 22, 2023
Tickers
CRSP
From Benzinga
Better Buy: Beam Therapeutics or Intellia Therapeutics?
February 22, 2023
From Motley Fool
2 Bruised Growth Stocks to Buy While They're Cheap
February 21, 2023
From Motley Fool
2 Marvelous Growth Stocks to Buy Today and Hold for 5 Years or Longer
February 18, 2023
From Motley Fool
These 2 Biotech Stocks Could Soar in the Next Bull Market
February 17, 2023
From Motley Fool
3 Prime Healthcare Takeover Targets
February 14, 2023
From Motley Fool
The Best Stocks To Invest $5,000 in Right Now
February 12, 2023
From Motley Fool
These Cheap Growth Stocks Could Supercharge Your Portfolio
February 12, 2023
From Motley Fool
Could CRISPR Therapeutics Stock Help You Become a Millionaire?
February 10, 2023
Tickers
CRSP
From Motley Fool
Is Vertex Pharmaceuticals Stock a Buy Right Now?
February 10, 2023
From Motley Fool
2 Biotech Stocks That Could Make You Richer
February 09, 2023
From Motley Fool
Better Bull Market Buy: CRISPR Therapeutics or Vertex Pharmaceuticals?
February 09, 2023
From Motley Fool
Tickers
CRSP
From Motley Fool
1 Beaten-Down Stock That Has a Lot to Prove in 2023
February 08, 2023
From Motley Fool
3 Top Stocks to Buy If There Is a Market Pullback
February 07, 2023
From Motley Fool
Ready to Buy the Dip? Consider This Gene Editing Stock
February 06, 2023
Tickers
CRSP
From Motley Fool
3 Cathie Wood Stocks Wall Street Thinks Can Soar 60% to 129%
February 06, 2023
From Motley Fool
3 No-Brainer Growth Stocks to Buy in 2023
February 03, 2023
From Motley Fool
Why Editas Medicine's Shares Jumped This Week
February 03, 2023
From Motley Fool
Is Editas Medicine Stock a Buy Now?
February 03, 2023
From Motley Fool
3 CRISPR Stocks to Buy Now Or You’ll Be Kicking Yourself Later
February 02, 2023
From InvestorPlace
Michael Burry vs. Jim Cramer: Is It Time to Buy or Sell Stocks Now?
February 02, 2023
From InvestorPlace
Analyst Initiates Coverage On This Peer Lagging Gene-Editing Stock
February 01, 2023
From Benzinga
Jim Cramer Says This Is 'One Of Those Crazy Science Stocks That In This Market Will Work Perfectly'
February 01, 2023
From Benzinga
3 Things About CRISPR Therapeutics That Smart Investors Know
January 31, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.